Compare PRDO & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRDO | BHC |
|---|---|---|
| Founded | 1994 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.0B |
| IPO Year | 1997 | 1996 |
| Metric | PRDO | BHC |
|---|---|---|
| Price | $36.50 | $5.93 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 3 |
| Target Price | ★ $42.00 | $8.33 |
| AVG Volume (30 Days) | 524.1K | ★ 1.2M |
| Earning Date | 05-05-2026 | 04-29-2026 |
| Dividend Yield | ★ 1.65% | N/A |
| EPS Growth | 10.50 | ★ 423.08 |
| EPS | ★ 2.42 | 0.42 |
| Revenue | $581,296,000.00 | ★ $8,724,000,000.00 |
| Revenue This Year | $4.28 | $4.61 |
| Revenue Next Year | $2.89 | N/A |
| P/E Ratio | $15.02 | ★ $14.07 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $24.29 | $4.41 |
| 52 Week High | $38.50 | $8.69 |
| Indicator | PRDO | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 56.12 | 64.66 |
| Support Level | $34.13 | $5.89 |
| Resistance Level | $37.96 | $6.32 |
| Average True Range (ATR) | 0.94 | 0.19 |
| MACD | -0.20 | 0.09 |
| Stochastic Oscillator | 55.70 | 95.40 |
Perdoceo Education Corp is an American for-profit education company that focuses on quality postsecondary education online to a diverse student population, along with campus-based and blended learning programs. The company's important segments include the American InterContinental University, the University of St. Augustine for Health Sciences, and Colorado Technical University. These universities provide undergraduate, graduate, and doctoral degree programs focusing on business, technology, management, and social services, with the majority of the students enrolled in programs offered fully online. The majority of the its revenue comes from the Colorado Technical University segment.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.